Open Access

Anticoagulation in atrial fibrillation: what the trials tell us and gaps in current knowledge.

Topic: Stroke Prevention
Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Congress Session

About the speaker

Professor Renato Lopes

Duke University Medical Center, Duke Clinical Research Institute, Durham (United States of America)
20 presentations
0 follower

5 more presentations in this session

Evolution in atrial fibrillation patient care for stroke prevention.

Speaker: Professor H. Heidbuchel (Edegem, BE)


Recent advances in the management of NOACs during interventional procedures.

Speaker: Professor L. Di Biase (The Bronx, US)


Beyond trials: learning from clinical practice.

Speaker: Professor G. Lip (Liverpool, GB)


Better use of scientific evidence in clinical practice.

Speaker: Professor H. Heidbuchel (Edegem, BE)


The evolving role of NOACs in AF patient care – Q&A.

Speaker: Professor H. Heidbuchel (Edegem, BE)


Access the full session

Advances in anticoagulation to improve patient care in atrial fibrillation

Speakers: Professor R. Lopes, Professor H. Heidbuchel, Professor L. Di Biase, Professor G. Lip, Professor H. Heidbuchel...

About the event


ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk